Depletion of PRMT5 results in alterations in mRNA alternative splicing and decreased levels of vital proteins that facilitate the growth of AML, including POLD1, POLD2, PPP1R7, PNISR, FDPS, PNKP, and PDCD2 [76]. Here, PRMT5 is linked to acute myeloid leukemia.